Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Solid Tumor 1 Noonan Syndrome 6 1 Neoplasms, Unknown Primary 1 Melanoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Unresectable or Metastatic Solid Malignancy 1

Interventions

Carboplatin 235 Pemetrexed 214 Paclitaxel 160 Cisplatin 150 pembrolizumab 145 Erlotinib Hydrochloride 141 Docetaxel 133 Gemcitabine 94 Bevacizumab 85 Nivolumab 72 Radiotherapy 62 atezolizumab 40 Radiosurgery 37 Afatinib 37 osimertinib 35 130-nm albumin-bound paclitaxel 35 Cetuximab 34 durvalumab 33 Ipilimumab 32 Gefitinib 31 Albumin-Bound Paclitaxel 29 Vinorelbine 23 Taxes 22 Etoposide 20 Crizotinib 19 Radiation 17 Sorafenib 16 Cyclophosphamide 16 Dexamethasone 15 Magnetic Resonance Spectroscopy 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Carcinoma, Non-Small-Cell Lung × entrectinib × Clear all

NCT05834348 2025-03-30

DELINOR

Pfizer

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡